Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 7 studies | 24% ± 6% | |
B cell | 5 studies | 16% ± 1% | |
macrophage | 4 studies | 27% ± 8% | |
non-classical monocyte | 4 studies | 25% ± 4% | |
epithelial cell | 4 studies | 34% ± 9% | |
ciliated cell | 4 studies | 24% ± 5% | |
pancreatic A cell | 3 studies | 21% ± 3% | |
conventional dendritic cell | 3 studies | 29% ± 5% | |
enterocyte | 3 studies | 19% ± 2% | |
alveolar macrophage | 3 studies | 17% ± 1% | |
endothelial cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 920.18 | 180 / 180 | 100% | 17.27 | 430 / 430 |
uterus | 100% | 1309.47 | 170 / 170 | 100% | 19.99 | 459 / 459 |
lung | 100% | 1531.93 | 578 / 578 | 100% | 18.85 | 1154 / 1155 |
brain | 100% | 1365.32 | 2638 / 2642 | 100% | 29.41 | 705 / 705 |
breast | 100% | 1384.75 | 459 / 459 | 100% | 22.70 | 1116 / 1118 |
intestine | 100% | 1586.30 | 966 / 966 | 100% | 19.09 | 526 / 527 |
esophagus | 100% | 1509.84 | 1441 / 1445 | 100% | 18.56 | 183 / 183 |
stomach | 100% | 1199.67 | 359 / 359 | 100% | 19.55 | 285 / 286 |
bladder | 100% | 1619.38 | 21 / 21 | 100% | 19.68 | 502 / 504 |
adrenal gland | 100% | 1387.88 | 258 / 258 | 100% | 25.31 | 229 / 230 |
thymus | 100% | 1112.60 | 652 / 653 | 100% | 21.27 | 602 / 605 |
prostate | 100% | 1249.11 | 244 / 245 | 100% | 16.41 | 500 / 502 |
liver | 99% | 868.26 | 224 / 226 | 100% | 19.11 | 405 / 406 |
kidney | 100% | 1320.08 | 89 / 89 | 98% | 16.98 | 887 / 901 |
skin | 98% | 1205.42 | 1772 / 1809 | 100% | 28.09 | 471 / 472 |
pancreas | 94% | 526.96 | 307 / 328 | 99% | 19.25 | 176 / 178 |
adipose | 100% | 1636.72 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1822.90 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.42 | 29 / 29 |
muscle | 100% | 2643.52 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1047.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.84 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.37 | 1 / 1 |
heart | 96% | 1183.05 | 825 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 1038.28 | 843 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 12.41 | 70 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051099 | Biological process | positive regulation of binding |
GO_0002926 | Biological process | tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation |
GO_0050709 | Biological process | negative regulation of protein secretion |
GO_0017183 | Biological process | protein histidyl modification to diphthamide |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008198 | Molecular function | ferrous iron binding |
GO_0005515 | Molecular function | protein binding |
GO_0034986 | Molecular function | iron chaperone activity |
Gene name | DPH3 |
Protein name | Diphthamide biosynthesis protein 3 (CSL-type zinc finger-containing protein 2) (DelGEF-interacting protein 1) (DelGIP1) |
Synonyms | ZCSL2 DESR1 |
Description | FUNCTION: Required for the first step of diphthamide biosynthesis, a post-translational modification of histidine which occurs in elongation factor 2. DPH1 and DPH2 transfer a 3-amino-3-carboxypropyl (ACP) group from S-adenosyl-L-methionine (SAM) to a histidine residue, the reaction is assisted by a reduction system comprising DPH3 and a NADH-dependent reductase. Acts as an electron donor to reduce the Fe-S cluster in DPH1-DPH2 keeping the [4Fe-4S] clusters in the active and reduced state. Restores iron to DPH1-DPH2 iron-sulfur clusters which have degraded from [4Fe-4S] to [3Fe-4S] by donating an iron atom to reform [4Fe-4S] clusters, in a manner dependent on the presence of elongation factor 2 and SAM. Associates with the elongator complex and is required for tRNA Wobble base modifications mediated by the elongator complex. The elongator complex is required for multiple tRNA modifications, including mcm5U (5-methoxycarbonylmethyl uridine), mcm5s 2U (5-methoxycarbonylmethyl-2-thiouridine), and ncm5U (5-carbamoylmethyl uridine). . |
Accessions | ENST00000488423.2 [Q96FX2-1] Q96FX2 ENST00000383775.4 [Q96FX2-2] |